4/7
07:00 am
skye
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
Low
Report
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
4/2
08:09 pm
skye
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development [Yahoo! Finance]
Medium
Report
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development [Yahoo! Finance]
4/2
07:00 am
skye
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
Medium
Report
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
3/11
09:35 pm
skye
Skye Bioscience Inc (SKYE) Q4 2025 Earnings Call Highlights: Pioneering Advances in Obesity ... [Yahoo! Finance]
Low
Report
Skye Bioscience Inc (SKYE) Q4 2025 Earnings Call Highlights: Pioneering Advances in Obesity ... [Yahoo! Finance]
3/10
09:07 pm
skye
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/10
04:01 pm
skye
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3/5
07:41 am
skye
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026 [Yahoo! Finance]
Low
Report
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026 [Yahoo! Finance]
3/5
07:00 am
skye
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
Low
Report
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
2/2
07:13 am
skye
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide [Yahoo! Finance]
High
Report
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide [Yahoo! Finance]
2/2
07:00 am
skye
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
High
Report
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
1/29
07:00 am
skye
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference
Low
Report
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference
1/21
07:00 am
skye
Skye Bioscience to Present Poster at Keystone Obesity Conference
Low
Report
Skye Bioscience to Present Poster at Keystone Obesity Conference
1/20
11:19 am
skye
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm
1/19
02:13 am
skye
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
Low
Report
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
1/19
02:04 am
skye
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Low
Report
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm